TFEB ‐translocated and ‐amplified renal cell carcinoma with VEGFA co‐amplification: A case of long‐term control by multimodal therapy including a vascular endothelial growth factor‐receptor inhibitor

INTRODUCTION: Renal cell carcinoma with TFEB amplification is rare and reportedly aggressive. We herein report a case of renal cell carcinoma with TFEB translocation and amplification in which long‐term control was achieved by multimodal therapy including a vascular endothelial growth factor ‐recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamori, Hajime, Maeshima, Akiko Miyagi, Kato, Ikuma, Baba, Masaya, Nakamura, Eijiro, Matsui, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151203/
https://www.ncbi.nlm.nih.gov/pubmed/37144078
http://dx.doi.org/10.1002/iju5.12575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151203/
https://www.ncbi.nlm.nih.gov/pubmed/37144078
http://dx.doi.org/10.1002/iju5.12575

Ejemplares similares